The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Let-7a microRNA levels in KRAS-mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR.
E. Canestrari
No relevant relationships to disclose
A. Ruzzo
No relevant relationships to disclose
B. Vincenzi
No relevant relationships to disclose
N. Galluccio
No relevant relationships to disclose
G. Perrone
No relevant relationships to disclose
F. Andreoni
No relevant relationships to disclose
P. Lorenzini
No relevant relationships to disclose
E. Rulli
No relevant relationships to disclose
S. d'Emidio
No relevant relationships to disclose
V. Catalano
No relevant relationships to disclose
F. Loupakis
No relevant relationships to disclose
R. Bisonni
No relevant relationships to disclose
I. Floriani
No relevant relationships to disclose
M. De Nictolis
No relevant relationships to disclose
D. Santini
No relevant relationships to disclose
L. Salvatore
No relevant relationships to disclose
G. Tonini
No relevant relationships to disclose
A. Falcone
No relevant relationships to disclose
M. Magnani
No relevant relationships to disclose
F. Graziano
No relevant relationships to disclose